Related Experiment Video
Updated: Jun 13, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Antibiotic policy in critical patients]
F Alvarez Lerma1, R Sierra Camerino, L Alvarez Rocha
1Servicio de Medicina Intensiva, Hospital del Mar, Barcelona, España. Falvarez@imas.imim.es
Abstract:
The combination of guidelines and strategies developed to improve and optimize the use of antimicrobials receives the name of antibiotic policy. Critical patients admitted to the Intensive Medicine Services have special characteristics (severity, pathogen agents, organ and/or system disorders) that justify the use of antibiotics differentially than for other hospitalized patients. The influence and impact of the antibiotics are observed in the patients who receive them (clinical response, course) and in the ecosystem surrounding the patient (hospital flora). This impact is especially visible in the critical patients in the endemic flora of the ICU. This article describes a combination of guidelines (guideline decalogue) and strategies (therapeutic de-escalation, cycling of antibiotics, preemptive treatment and pharmacokinetic/pharmacodynamic parameters) that have been applied and developed in the critical patients to optimize the use of the antimicrobials in order to achieve the maximum effectivity and minimum morbidity.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Microbiota Modulation by Antibiotics
Antibiotic Selection
Mechanism of Antibiotic Resistance in MRSA
Urine Studies II: Urine Culture and Sensitivity Test